NA

Nuode Asset Management

Asia, Shanghai, China, Shanghai

Description

Nuode Asset Management is a fund management company based in China.

Investor Profile

Nuode Asset Management has backed more than 7 startups, with 5 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Manufacturing, Medical, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Medical
  • Pharmaceutical
  • Enterprise
  • Aerospace
  • Industrial
  • Industrial Manufacturing
  • Furniture
  • Chemical
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nuode Asset Management frequently co-invest with?

China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 3
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
Cinda Securities
Asia, Beijing, China, Beijing
Co-Investments: 1
Caitong Fund Management Co.
Asia, Shanghai, China, Shanghai
Co-Investments: 5
GF Securities
Asia, Guangdong, China, Guangzhou
Co-Investments: 2
Guotai Junan Securities
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Huaan Securities
Asia, Anhui, China, Hefei
Co-Investments: 2
China Merchants Bank
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
UBS
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Huatai Insurance Group
Asia, Beijing, China, Beijing
Co-Investments: 3

Which angels does Nuode Asset Management often collaborate with?

Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Nuode Asset Management?

Shengda Bio-Pharm

Taizhou, Jiangsu, China

Shengda Biopharmaceutical offers the production and sale of food and feed additives.

MedicalPharmaceutical
Post Ipo EquityJun 17, 2025
Amount Raised: $36,403,852
Dizal Pharma

Shanghai, Shanghai, China

Dizal Pharma is a research-based biotechnology company.

BiotechnologyPharmaceutical
Post Ipo EquityApr 17, 2025
Amount Raised: $246,169,029
Sanyou Medical

Shanghai, Shanghai, China

Sanyou Medical is a corporation that is therapy innovation oriented and devotes to the R&D.

Innovation ManagementMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 13, 2025
Amount Raised: $29,566,791
Guangdong Guanghua Sci-tech

Shantou, Guangdong, China

GHTECH is a chemical service provider.

ChemicalElectronicsManufacturing
Post Ipo EquityNov 25, 2024
Amount Raised: $94,952,213
AVICOPTER PLC

Harbin, Heilongjiang, China

AVIC Helicopter designs, develops, manufactures, and sells helicopters, airplane parts, and aviation-related products.

AerospaceIndustrialIndustrial Manufacturing
Post Ipo EquityJul 25, 2024
Amount Raised: $415,633,352
Qumei Home Furnishing Group

Beijing, Beijing, China

QuMei Home Furnishings Group designs, manufactures, and markets furniture products in China.

FurnitureManufacturing
Post Ipo EquityJan 10, 2024
Amount Raised: $76,038,719
DFD

Jiaozuo, Henan, China

DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides.

EnterpriseManufacturing
Post Ipo EquityAug 17, 2023
Amount Raised: $274,672,453